An internal standard for the quantification of dexmedetomidine
Related Products
Unlabeled Version(s)
39544Dexmedetomidine
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Dexmedetomidine-d3 (tartrate)

Item No. 43801

Technical Information
Formal Name
5-[(1S)-1-(2,3-dimethylphenyl)ethyl-2,2,2-d3]-1H-imidazole, 2R,3R-dihydroxybutanedioate
Synonyms
  • MPV 1440-d3
Molecular Formula
C13H13D3N2 • C4H6O6
Formula Weight
Purity
≥99% deuterated forms (d1-d3)
Formulation
A solid
Acetonitrile: Slightly solubleDMSO: SolubleWater: Slightly soluble
SMILES
CC1=C(C)C([C@H](C([2H])([2H])[2H])C2=CN=CN2)=CC=C1.O=C(O)[C@H](O)[C@@H](O)C(O)=O
InChi Code
InChI=1S/C13H16N2.C4H6O6/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13;5-1(3(7)8)2(6)4(9)10/h4-8,11H,1-3H3,(H,14,15);1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m01/s1/i3D3;
InChi Key
ITWNPJSUZOQVNY-BITIEFMISA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Dexmedetomidine-d3 is intended for use as an internal standard for the quantification of dexmedetomidine (Item No. 39544) by GC- or LC-MS. Dexmedetomidine is an agonist of α2-adrenergic receptors (α2-ARs).1 It selectively binds to α2-ARs over α1-ARs (Kis = 0.015 and 5 nM, respectively). In vivo, dexmedetomidine (50 µg/kg) prevents increases in cardiac troponin I (CTnI), a marker of myocardial injury, as well as reduces myocardial apoptosis, pyroptosis, and ferroptosis in a mouse model of sepsis induced by cecal ligation and puncture (CLP), effects that can be reversed by the α2-AR antagonist yohimbine (Item No. 19869).2 Dexmedetomidine (40 µg/kg) induces sedation and decreases mechanical nociception in cats.3 Formulations containing dexmedetomidine have been used as sedatives.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ross, T.M., Jetter, M.C., McDonnell, M.E., et alα2 Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-imidazo)-1,3-dimethyl-6,7-dihydro-thianaphthene as a high-affinity ligand for the α2D adrenergic receptor. J. Med. Chem. 43(7), 1423-1426 (2000).

    2. Wang, C., Yuan, W., Hu, A., et alDexmedetomidine alleviated sepsis‑induced myocardial ferroptosis and septic heart injury. Mol. Med. Rep. 22(1), 175-184 (2020).

    3. Nagore, L., Soler, C., Gil, L., et alSedative effects of dexmedetomidine, dexmedetomidine-pethidine and dexmedetomidine-butorphanol in cats. J. Vet. Pharmacol. Ther. 6(3), 222-228 (2013).